The future of cardiotoxicity research involves the development of more sensitive biomarkers and imaging techniques to detect early signs of cardiac damage. The use of 3D cardiac tissue models and patient-specific stem cell-derived cardiomyocytes offers promising avenues for personalized medicine approaches to evaluate and predict cardiotoxic risk.
Understanding cardiotoxic agents is essential in the field of toxicology, as they pose significant health risks. Ongoing research and advancements in detection and prevention strategies continue to improve patient outcomes and safety in the use of potentially cardiotoxic substances.
